Skip to main content

Month: August 2022

Capital Power announces a 6% dividend increase for its common shares and declares dividends for its Preference shares

EDMONTON, Alberta, Aug. 02, 2022 (GLOBE NEWSWIRE) — The Board of Directors for Capital Power Corporation (TSX: CPX) (Capital Power) declared a dividend of $0.58 per share on the outstanding common shares for the quarter ending September 30, 2022. The dividend is payable on October 31, 2022 to shareholders of record at the close of business on September 30, 2022. The quarterly dividend of $0.58 per common share compared to the previous $0.5475 dividend represents a 6% increase, and an annualized dividend of $2.32 per common share. The Board of Directors also declared the following dividends on its Cumulative Rate Reset Preference Shares:Shares TSX Stock Symbol Dividend Per Share Record Date Payment DateSeries 1 CPX.PR.A $0.1638125 September 19, 2022 September 30, 2022Series 3 CPX.PR.C $0.3408125 September 19, 2022 September...

Continue reading

Converge Technology Solutions Corp. Completes Acquisition of PC Specialists, Inc. d/b/a Technology Integration Group

TORONTO and GATINEAU, Quebec, Aug. 02, 2022 (GLOBE NEWSWIRE) — Converge Technology Solutions Corp. (“Converge” or “the Company”) (TSX:CTS) (FSE:0ZB) (OTCQX:CTSDF) a software-enabled IT & Cloud Solutions provider, is pleased to announce the closing of its previously signed acquisition of PC Specialists, Inc. d/b/a Technology Integration Group (“TIG”). Converge announced the signing of the acquisition of TIG on May 19, 2022. Headquartered in San Diego, CA with 20 offices across North America, TIG specializes in optimized performance solutions and critical business support. From software and hardware procurement to discovery assessments, strategic planning, deployment, data center optimization, IT asset management and cloud computing, TIG offers custom-built IT solutions for clients around the globe, with a major presence in...

Continue reading

NYI Expands 60 Hudson Street Operations

The acquisition of the Equinix NY8 facility brings additional datacenter capacity and cost-effective access to a broad carrier ecosystem in New York City60 Hudson Street, New York City A global interconnection hubNEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) — NYI, a leading provider of hybrid infrastructure solutions and managed services, has expanded its 60 Hudson Street operations through the addition of space formerly occupied by Equinix. The expansion is the result of a joint venture with QTD Systems, who acquired the Equinix space in a transaction that closed on August 1, 2022. With this integration, NYI doubles its datacenter footprint and immediately expands the carrier ecosystem available to customers. The expansion also includes significant additional conduit infrastructure and access to POE’s which will provide for unmatched...

Continue reading

Daseke Reports Results for Second Quarter 2022

Differentiated operational flexibility and demand-driven rate strength combine to deliver year-over-year improvements in the quarter; company raises full year revenue guidance ADDISON, Texas, Aug. 02, 2022 (GLOBE NEWSWIRE) — Daseke, Inc. (NASDAQ: DSKE) (“Daseke” or the “Company”), the premier North American transportation solutions specialist dedicated to servicing challenging industrial end-markets, today reported financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Highlights:Revenue of $481.3 million, up 19.1% year-over-year Net Income of $17.7 million, or $0.24 per diluted share attributable to common stockholders, compared to net income of $35.3 million, or $0.49, in the second quarter of 2021 Adjusted Net Income of $30.0 million, or $0.42 per diluted share attributable to common stockholders,...

Continue reading

Form 8.3 – [CareTech Holdings plc – 01 08 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree CARETECH HOLDINGS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Green Plains Partners Reports Second Quarter 2022 Financial Results

Results for the Second Quarter of 2022Net income of $10.5 million, or $0.44 per common unit Adjusted EBITDA of $12.9 million and distributable cash flow of $11.3 million Quarterly cash distribution increased to $0.45 per unit Distribution coverage ratio of 1.06x; LTM distribution coverage ratio of 1.07x Leverage ratio, net of cash; 0.82x Adjusted EBITDAOMAHA, Neb., Aug. 02, 2022 (GLOBE NEWSWIRE) — Green Plains Partners LP (NASDAQ:GPP) today announced financial and operating results for the second quarter of 2022. Net income attributable to the partnership was $10.5 million, or $0.44 per common unit, for the second quarter of 2022, compared with net income of $10.3 million, or $0.44 per common unit, for the same period in 2021. The partnership also reported adjusted EBITDA of $12.9 million and distributable cash flow of $11.3...

Continue reading

Green Plains Reports Second Quarter 2022 Financial Results

Results for the Second Quarter of 2022:Second quarter net income attributable to Green Plains of $46.4 million and EPS of $0.73 per diluted share, compared to net income attributable to Green Plains of $9.7 million and EPS of $0.20 per diluted share for the same period in the prior year EBITDA of $84.4 million, inclusive of a USDA COVID relief payment of $27.7 million, compared to $50.9 million for the same period in the prior year Consolidated crush margin of $0.28 per gallon for the second quarter Plant utilization rate of 96.9%, demonstrating the ability of our upgraded production platform $604.2 million of cash, cash equivalents, restricted cash and marketable securities; $70.0 million available under a committed credit facility Commissioning of the MSC™ system in Central City, Nebraska, began in July and anticipate commissioning...

Continue reading

Harmony Biosciences Reports Second Quarter 2022 Financial Results and Business Updates

WAKIX®(pitolisant) Net Revenue of $107.0 Million for Second Quarter 2022 Increase of 45% vs. the Same Period in 2021 Average Number of Patients on WAKIX Increased to ~4,300 Signs New Agreement with Bioprojet Focused on Developing Innovative Therapeutics Based on Pitolisant, Expanding Harmony’s Opportunity in Narcolepsy Phase 3 Idiopathic Hypersomnia (IH) INTUNE Study on Track with Site Activations and Patient Enrollment Conference Call and Webcast to be Held Today at 8:30 a.m. ET PLYMOUTH MEETING, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) — Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (Nasdaq: HRMY), a pharmaceutical company focused on delivering innovative therapies that improve the health of people living with rare neurological diseases, today reported financial results and business updates for the quarter ended...

Continue reading

Repligen Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Financial Guidance

Record revenue of $207.6 million for the quarter, representing overall growth of 27% as reported and 32% at constant currency (year-over-year) Strong organic revenue growth of 29% and strong base business growth of 41% for the quarter Revenue guidance raised to $790 – $810 million for full year 2022WALTHAM, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its second quarter ended June 30, 2022. Provided in this press release are financial highlights for the three- and six-month periods ended June 30, 2022, updates to our financial guidance for the year 2022 and access information for today’s webcast and conference call. Tony J. Hunt, President and Chief Executive Officer said, “I’m very...

Continue reading

Surgery Partners, Inc. Announces Second Quarter 2022 Results

Revenue increased 13.3% from the prior year period to $615.4 millionDays adjusted same-facility revenues increased 6.9% from the prior year periodNet loss attributable to common stockholders was $18.4 millionAdjusted EBITDA increased 13.4% over the prior year period to $86.1 million, inclusive of a $0.1 million benefit from the recognition of CARES Act grants Excluding CARES Act grants, Adjusted EBITDA increased 17.8% over the prior year period, with Adjusted EBITDA margins of 14.0%Reaffirm projected 2022 Adjusted EBITDA in the range of $375 million to $385 million and 2022 revenue in the range of $2.5 billion to $2.6 billionBRENTWOOD, Tenn., Aug. 02, 2022 (GLOBE NEWSWIRE) — Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading provider of surgical services,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.